Chimerix reported $333K in Cost of Sales for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
Ardelyx ARDX:US USD 732K 594K
Chimerix CMRX:US USD 333K 333K
Curis CRIS:US USD 62K 20K
Dynavax Technologies DVAX:US USD 61.33M 22.04M
Emergent Biosolutions EBS:US USD 148.6M 21.2M
Gilead Sciences GILD:US USD 1.4B 47M
Glaxosmithkline GSK:US GBP 2.39B 250M
Merk MRK:US USD 3.43B 715M
Novavax NVAX:US USD 434.59M 163.52M